Today we are launching the Catalyst Pharma Fast 50, which ranks the fastest-growing, privately owned pharmaceutical businesses in the UK. The UK pharma industry is a world-leader in R&D and innovation, and stands out for the quality of management and talent in both large pharma and the increasing number of small and medium-sized payers. 

The Pharma Fast 50 places the spotlight on the leading companies in the sector, ranging from pharma outsourcing and product supply businesses to consultants. These companies are bringing innovative products and services to market, taking advantage of the opportunities which the trends underpinning the pharma industry and global demand for medicines are creating.  

Over the next few days we’ll be publishing a series of blogs which discuss different aspects of our Pharma Fast 50 report, analysing what is driving change and generating growth opportunities, investment activity and the outlook for the industry. Many lessons can be drawn from the success of the fastest-growing companies. One overarching conclusion: the UK pharma industry is more dynamic than ever.